PharmaSite Research, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
PharmaSite Research, Inc. - overview
Location
-, MD, US
Primary Industry
Pharmaceuticals
About
Based in Maryland, US, PharmaSite Research, Inc. , operates as a clinical research company conducting clinical trials for various health conditions, including depression, anxiety disorders, insomnia, bipolar disorder, attention-deficit hyperactivity disorder, and migraines. In February 2024, Headlands Research, Inc. , a portfolio company of KKR, acquired PharmaSite Research, Inc.
The company offers mental health disorders such as major depressive disorder (MDD), post-traumatic stress disorder (PTSD), treatment-resistant depression, mild cognitive impairment (MCI), alzheimer’s disease, and migraine. The company also provides clinical trials focused on mental health disorders, cognitive impairment, neurological conditions, and other health issues.
Current Investors
Headlands Research, Inc.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.